Abstract
Objective: Valvular lesions are frequently present in Primary Antiphospholipid Syndrome (PAPS) patients using transthoracic and/or transesophageal echocardiography. The aim of this study was to describe the prevalence of cardiac abnormalities (valvular thickening and/or regurgitation) or potential embolic sources (spontaneous echocontrast and/or vegetations) in PAPS patients. Methods: Multiplane transesophageal echocardiography was performed consecutively on 40 PAPS patients: 17 of them with thrombocytopenia, 27 with at least one thromboembolic event (stroke, transient ischaemic attack, arterial and/or venous thrombosis, pulmonary embolism) and 14 with recurrent fetal loss. Design: Cardiac involvement (cardiac abnormalities and/or embolic sources) was present in 33/40 (82%) of PAPS patients. According to aCL titer these lesions were revealed in 17/24 (71%) of patients with aCL ≤ 40 GPL-U, while these lesions were present in 100% of patients with aCL > 40 GPL-U. Three patients presented mitral stenosis and 3 non-infective valve masses or vegetations. Embolic sources were found in 4/24 (17%) patients with aCL ≤ 40 GPL-U, while they were observed in 6/16 (37%) of patients with titer of aCL > 40 GPL-U (χ2 = 10.03, P <0.01). Regression analysis showed a positive correlation between mitral valve thickening and aCL antibodies titer (r = 0.5; P <0.001). Conclusions: Valvular lesions are commonly found in PAPS patients. Our data showed a significant correlation among aCL titer, mitral leaflets thickening and thromboembolic events.
| Original language | English |
|---|---|
| Pages (from-to) | 406-412 |
| Number of pages | 7 |
| Journal | Lupus |
| Volume | 9 |
| Issue number | 6 |
| Publication status | Published - 2000 |
Fingerprint
Keywords
- aCL antibodies
- Embolic sources
- Primary antiphospholipid syndrome
- Transesophageal echocardiography
ASJC Scopus subject areas
- Rheumatology
- Immunology
Cite this
Evaluation of cardiac abnormalities and embolic sources in primary antiphospholipid syndrome by transesophageal echocardiography. / Turiel, M.; Muzzupappa, S.; Gottardi, B.; Crema, C.; Sarzi-Puttini, P.; Rossi, E.
In: Lupus, Vol. 9, No. 6, 2000, p. 406-412.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Evaluation of cardiac abnormalities and embolic sources in primary antiphospholipid syndrome by transesophageal echocardiography
AU - Turiel, M.
AU - Muzzupappa, S.
AU - Gottardi, B.
AU - Crema, C.
AU - Sarzi-Puttini, P.
AU - Rossi, E.
PY - 2000
Y1 - 2000
N2 - Objective: Valvular lesions are frequently present in Primary Antiphospholipid Syndrome (PAPS) patients using transthoracic and/or transesophageal echocardiography. The aim of this study was to describe the prevalence of cardiac abnormalities (valvular thickening and/or regurgitation) or potential embolic sources (spontaneous echocontrast and/or vegetations) in PAPS patients. Methods: Multiplane transesophageal echocardiography was performed consecutively on 40 PAPS patients: 17 of them with thrombocytopenia, 27 with at least one thromboembolic event (stroke, transient ischaemic attack, arterial and/or venous thrombosis, pulmonary embolism) and 14 with recurrent fetal loss. Design: Cardiac involvement (cardiac abnormalities and/or embolic sources) was present in 33/40 (82%) of PAPS patients. According to aCL titer these lesions were revealed in 17/24 (71%) of patients with aCL ≤ 40 GPL-U, while these lesions were present in 100% of patients with aCL > 40 GPL-U. Three patients presented mitral stenosis and 3 non-infective valve masses or vegetations. Embolic sources were found in 4/24 (17%) patients with aCL ≤ 40 GPL-U, while they were observed in 6/16 (37%) of patients with titer of aCL > 40 GPL-U (χ2 = 10.03, P <0.01). Regression analysis showed a positive correlation between mitral valve thickening and aCL antibodies titer (r = 0.5; P <0.001). Conclusions: Valvular lesions are commonly found in PAPS patients. Our data showed a significant correlation among aCL titer, mitral leaflets thickening and thromboembolic events.
AB - Objective: Valvular lesions are frequently present in Primary Antiphospholipid Syndrome (PAPS) patients using transthoracic and/or transesophageal echocardiography. The aim of this study was to describe the prevalence of cardiac abnormalities (valvular thickening and/or regurgitation) or potential embolic sources (spontaneous echocontrast and/or vegetations) in PAPS patients. Methods: Multiplane transesophageal echocardiography was performed consecutively on 40 PAPS patients: 17 of them with thrombocytopenia, 27 with at least one thromboembolic event (stroke, transient ischaemic attack, arterial and/or venous thrombosis, pulmonary embolism) and 14 with recurrent fetal loss. Design: Cardiac involvement (cardiac abnormalities and/or embolic sources) was present in 33/40 (82%) of PAPS patients. According to aCL titer these lesions were revealed in 17/24 (71%) of patients with aCL ≤ 40 GPL-U, while these lesions were present in 100% of patients with aCL > 40 GPL-U. Three patients presented mitral stenosis and 3 non-infective valve masses or vegetations. Embolic sources were found in 4/24 (17%) patients with aCL ≤ 40 GPL-U, while they were observed in 6/16 (37%) of patients with titer of aCL > 40 GPL-U (χ2 = 10.03, P <0.01). Regression analysis showed a positive correlation between mitral valve thickening and aCL antibodies titer (r = 0.5; P <0.001). Conclusions: Valvular lesions are commonly found in PAPS patients. Our data showed a significant correlation among aCL titer, mitral leaflets thickening and thromboembolic events.
KW - aCL antibodies
KW - Embolic sources
KW - Primary antiphospholipid syndrome
KW - Transesophageal echocardiography
UR - http://www.scopus.com/inward/record.url?scp=0033915833&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033915833&partnerID=8YFLogxK
M3 - Article
C2 - 10981643
AN - SCOPUS:0033915833
VL - 9
SP - 406
EP - 412
JO - Lupus
JF - Lupus
SN - 0961-2033
IS - 6
ER -